Madrigal Pharmaceuticals - 53 Year Dividend History | MDGL
Historical dividend payout and yield for Madrigal Pharmaceuticals (MDGL) since 1971. The current TTM dividend payout for Madrigal Pharmaceuticals (MDGL) as of April 19, 2024 is $0.00. The current dividend yield for Madrigal Pharmaceuticals as of April 19, 2024 is 0.00%.
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Drug Manufacturing |
$4.422B |
$0.000B |
|
Madrigal Pharmaceuticals, Inc. is engaged in developing small-molecule drugs addressing cardiovascular and metabolic diseases. Its products pipeline include MGL-3196, an orally administered liver-directed thyroid hormone receptor-? agonist that is used for the treatment of NASH, dyslipidemia/hypercholesterolemia and high triglycerides; and MGL-3745, a thyroid hormone receptor-? agonist which are in pre-clinical trial stage. Madrigal Pharmaceuticals Inc., formerly known as Synta Pharmaceuticals Corp., is based in Fort Washington, Pennsylvania.
|
| Stock Name |
Country |
Market Cap |
PE Ratio |
